Today marks the beginning of a new era in our quest to unlock the full capacity of stem cells to develop treatments and cures for diseases and conditions that plague humankind.
Like you, we listened today to President Obama’s announcement with enormous relief. We feel relief from the bureaucratic and accounting burdens that have slowed our work, discouraged young scientists, and delayed progress for nearly eight years. We feel relief that scientists can now collaborate openly and freely with other scientists in their own...
HSCI investigators at MGH will now have expedited access to mouse models made by the Genome Modification Facility (GMF). This is what Steven Niemi, DVM, Director of the Center for Comparative Medicine (CCM) at MGH announced in a recent email after completing an extensive review of the pathogen monitoring process at the Harvard facilities and the GMF. By adopting the Express Quarantine process, MGH will move GMF mice into their barrier facilities by 6 weeks of age, which effectively will eliminate any delays in setting up research colonies.
HSCI Principal Faculty member Konrad Hochedlinger, PhD, received the ISSCR Outstanding Young Investigator Award at the ISSCR 7th Annual Meeting in Barcelona. The award, which recognizes the exceptional achievements of an investigator in the early part of his or her independent career in stem cell research, includes a $7,500 personal award and complimentary registration to the ISSCR Annual Meeting where he was honored.
The Harvard Stem Cell Institute (HSCI) invites applications for seed grants funding. The purpose of this program is to provide early funding for innovative projects in the field of stem cell research including basic, translational and clinical research.... Read more about HSCI invites applications for seed grants